Erythrocyte-protective effect of sarpogrelate hydrochloride (Anplag^®), a selective 5-HT₂ receptor antagonist: an in vitro study

Author： Nakamura Ken Kawahito Koji

Publisher： Springer Publishing Company

ISSN： 1434-7229

Source： Journal of Artificial Organs, Vol.13, Iss.3, 2010-09, pp. : 178-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Conjunctive Effects of the 5HT₂ Receptor Antagonist, Sarpogrelate, on Thrombolysis with Modified Tissue Plasminogen Activator in Different Laser-Induced Thrombosis Models

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 6, 2001-05 ,pp. : 321-332

Karger

Access to resources Recommend Favorite

Astrocytic 5-HT2B Receptor as in vitro and in vivo Target of SSRIs

Recent Patents on CNS Drug Discovery, Vol. 7, Iss. 3, 2012-12 ,pp. : 243-253

Bentham Science Publishers

Access to resources Recommend Favorite

An overview of satavaptan: a selective V2 receptor antagonist

By Farah Jareer Daifallah Suleiman Zmily Hammam Ghali Jalal K

Therapy, Vol. 7, Iss. 4, 2010-07 ,pp. : 409-422

Future Medicine

Access to resources Recommend Favorite

Changes in Plasma Serotonin Concentration and Acceleration Plethysmograms in Patients with Raynaud's Phenomenon after Long‐term Treatment with a 5‐HT2 Receptor Antagonist

THE JOURNAL OF DERMATOLOGY, Vol. 27, Iss. 10, 2000-10 ,pp. : 643-650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serotonin (5‐HT)2A/2C receptor agonist (2,5‐dimethoxy‐4‐idophenyl)‐2‐aminopropane hydrochloride (DOI) improves voiding efficiency in the diabetic rat

BJU INTERNATIONAL, Vol. 116, Iss. 1, 2015-07 ,pp. : 147-155

John Wiley & Sons Inc

Access to resources Recommend Favorite